0
Lucid Diagnostics Inc. Banner Image

Lucid Diagnostics Inc.

  • Ticker LUCD
    Exchange NASDAQ More
  • Industry Medical Appliances & Equipment More
  • Sector Healthcare More
Lucid Diagnostics Inc. Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuardĀ® Esophageal DNA Test, performed on samples collected in a briefMore, noninvasive office procedure with its EsoCheckĀ® Esophageal Cell Collection Device - the first and only commercially available tools designed with the goal of preventing esophageal cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.
REPORT RATINGS
5.0 / 5.0 (1)

Lucid Diagnostics Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Lucid Diagnostics Inc.

Most Recent Annual Report

Lucid Diagnostics Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Lucid Diagnostics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!